Sort
82,697 grants matching “vaccine development”
STRUCTURAL STUDIES ON ROTAVIRUS
$775,925Bidadi V Venkataram Prasad · Baylor College Of Medicine · R01 · FY2023 · AI
Humoral Correlates of Protection Against HIV
$775,917Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2016 · AI
Animal Models to Study Plague Infection and Immunity
$775,914B Joseph Hinnebusch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults
$775,914John F Alcorn · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
Assembly of MHC Class I Molecules in Vitro and in Vivo
$775,905Hidde L Ploegh · Whitehead Institute For Biomedical Res · R01 · FY2008 · AI
Next Generation Crispr Ready, HLA Class I and II Transgenic Mouse Platform
$775,888Sujan Shresta · La Jolla Institute For Immunology · R24 · FY2025 · OD
The development of a recombinant vaccine against human onchocerciasis
$775,846Sara Lustigman · New York Blood Center · R01 · FY2021 · AI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome
$775,815Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
Development of a Safe and Potent Vaccine Against Melioidosis using the LVS dcapB Vector Platform
$775,812Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2021 · AI
Native American Research Centers For Health (NARCH XII)
$775,750Daniel J. Calac · Indian Health Council, Inc. · S06 · FY2025 · GM
Louisiana Clinical and Translational Science Center
$775,741John P. Kirwan · Lsu Pennington Biomedical Research Ctr · U54 · FY2023 · GM
Transcriptomic Signatures of Influenza Vaccine Responses
$775,707Gregory A. Poland · Mayo Clinic Rochester · R01 · FY2019 · AI
Multivalent Toxoid Vaccine for Prevention of S. aureus Invasive Diseases
$775,672M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2018 · AI
Control of Epidemic Influenza
$775,666Pedro A Piedra · Baylor College Of Medicine · R01 · FY2007 · AI
Immungen Design-Rational and Random Designs, and Env Receptor Mimetic Comp
$775,595Indresh K Srivastava · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2008 · AI
FcRn-targeted mucosal HIV vaccine
$775,556Charles David Pauza · University Of Maryland Baltimore · R01 · FY2012 · AI
Structural Studies of Human Papillomavirus
$775,542Susan Hafenstein · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2020 · AI
A NOVEL STRATEGY TO INHIBIT SARS-COV-2 INFECTION AND COVID-19
$775,538Philippe Andre Gallay · Scripps Research Institute, The · R01 · FY2024 · AI
Structure and immunogenicity of novel trimeric HIV-1 Env immunogens
$775,495Xiangpeng Kong · New York University School Of Medicine · R01 · FY2021 · AI
Ordered gene knockout libraries for Neisseria gonorrhoeae
$775,472H. Steven Seifert · Northwestern University At Chicago · R24 · FY2021 · AI
Enrichment of the State-1 Conformation of the HIV-1 Envelope Glycoprotein
$775,468Joseph G Sodroski · Dana-Farber Cancer Inst · R01 · FY2020 · AI
AUTOIMMUNITY--MECHANISMS OF UNRESPONSIVENESS
$775,464Stanford University · P01 · FY2000 · AI
COVID-19: Identification and Development of Clinical Candidates to Treat SARS-CoV-2
$775,431Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Antigenic determinants of asthma-associated allergens for design of immunotherapy
$775,425Anna Pomes · Indoor Biotechnologies · R01 · FY2025 · AI
NKT cells as modulators of AIDS vaccine efficacy
$775,402Amitinder Kaur · Harvard Medical School · R01 · FY2013 · AI